Columbia Sportswear Company (COLM) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Q1 2026 net sales were $779 million, flat year-over-year, with international growth offsetting a 10% decline in the U.S.; favorable FX impact of 280 bps.
Gross margin contracted 20 basis points to 50.7%, mainly due to incremental U.S. tariffs, partially offset by price increases.
Operating income declined 10% to $42 million, with net income down 19% to $34.3 million and diluted EPS at $0.65, down from $0.75.
Inventory units declined 11% year-over-year, with dollar value flat at $624 million.
Ended the quarter with $535.4 million in cash and short-term investments, no debt.
Financial highlights
SG&A expenses rose nearly 1% to $357.1 million (45.8% of sales), mainly due to higher DTC costs and unfavorable FX.
Operating margin for Q1 was 5.4%, down from 6.0% year-over-year.
Free cash flow for Q1 was negative $89.9 million, with operating cash flow at negative $77.5 million.
$150 million in share repurchases completed in Q1 2026.
Quarterly dividend of $0.30 per share declared.
Outlook and guidance
FY2026 net sales expected at $3.43–$3.50 billion, up 1%–3% year-over-year.
Gross margin outlook improved to 50.3%–50.5%, reflecting a 20 bps contraction to flat year-over-year.
Operating margin guidance raised to 6.7%–7.5%; diluted EPS forecasted at $3.55–$4.00.
Q2 2026 net sales expected between $600M–$610M (down 1% to up 1% year-over-year); projected loss per share of $0.46 to $0.37.
FY2026 capex planned at $65–$75 million, focused on DTC and digital.
Latest events from Columbia Sportswear Company
- 2025 delivered modest sales growth, strong global expansion, and robust financial discipline.COLM
Investor presentation30 Apr 2026 - 2026 annual meeting covers director elections, pay, stock plan, and proxy access, with Board opposition to proxy access.COLM
Proxy filing24 Apr 2026 - Key votes include board elections, auditor ratification, and a proxy access proposal.COLM
Proxy filing24 Apr 2026 - Q4 sales fell 2% but margin rose; 2026 outlook sees 1–3% growth and tariff pressure.COLM
Q4 20254 Feb 2026 - Q2 sales fell 8% with a net loss, but strong cash and inventory cuts support a steady outlook.COLM
Q2 20242 Feb 2026 - Q3 sales fell 5% as North America lagged, but gross margin rose and EPS guidance increased.COLM
Q3 202417 Jan 2026 - 2025 outlook targets modest growth, margin gains, and brand investment, led by EMEA and LAAP.COLM
Q4 20248 Jan 2026 - Q1 sales up 1%, margin gains, but outlook withdrawn amid tariff and macro uncertainty.COLM
Q1 20256 Jan 2026 - Board recommends all director nominees, auditor ratification, and opposes new GHG targets.COLM
Proxy Filing1 Dec 2025